A4I Antagonist

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A4I Antagonist, covering 2016-08-24 to 2016-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis. [Phase 2]